Key Financial Inc’s BioMarin Pharmaceuticals BMRN Stock Holding History

Key Financial Inc’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$515	Hold	9	–	–	﹤0.01%	1266
2026 Q1	$508	Hold	9	–	–	﹤0.01%	1305
2025 Q4	$535	Hold	9	–	–	﹤0.01%	1323
2025 Q3	$494	Hold	9	–	–	﹤0.01%	1340
2025 Q2	$495	Hold	9	–	–	﹤0.01%	1328
2025 Q1	$636	Hold	9	–	–	﹤0.01%	1264
2024 Q4	$592	Hold	9	–	–	﹤0.01%	1272
2024 Q3	$633	Hold	9	–	–	﹤0.01%	1237
2024 Q2	$741	Hold	9	–	–	﹤0.01%	1212
2024 Q1	$786	Hold	9	–	–	﹤0.01%	1200
2023 Q4	$868	Hold	9	–	–	﹤0.01%	1199
2023 Q3	$796	Hold	9	–	–	﹤0.01%	1215
2023 Q2	$780	Hold	9	–	–	﹤0.01%	1262
2023 Q1	$875	Hold	9	–	–	﹤0.01%	1051
2022 Q4	$763	Hold	9	–	–	﹤0.01%	1062
2022 Q3	$1K	Hold	9	–	–	﹤0.01%	1004
2022 Q2	$1K	Hold	9	–	–	﹤0.01%	988
2022 Q1	$1K	Hold	9	–	–	﹤0.01%	981
2021 Q4	$1K	Hold	9	–	–	﹤0.01%	867
2021 Q3	$1K	Sell	9 -91	-91%	-$7.18K	﹤0.01%	845
2021 Q2	$8K	Hold	100	–	–	﹤0.01%	610
2021 Q1	$8K	Hold	100	–	–	0.01%	516
2020 Q4	$9K	Buy	+100	New	+$7.93K	0.01%	471

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Key Financial Inc's BMRN Position: Q2 2026 in Review

Key Financial Inc held its BioMarin Pharmaceuticals (BMRN) position steady in Q2 2026 at 9 shares worth $515. The position accounts for ﹤0.01% of the portfolio, ranked #1266.

Key Financial Inc first reported a position in BMRN in Q4 2020 and has held it in 23 quarters since. The position peaked at $9K in Q4 2020. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Key Financial Inc held 9 shares of BioMarin Pharmaceuticals worth $515 as of Q2 2026.
Key Financial Inc left its BioMarin Pharmaceuticals share count unchanged in Q2 2026.
BioMarin Pharmaceuticals made up ﹤0.01% of Key Financial Inc's portfolio in Q2 2026, its #1266 holding.
Key Financial Inc first reported a position in BioMarin Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
Key Financial Inc's BioMarin Pharmaceuticals position peaked at $9K in Q4 2020.
565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.